These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37622228)

  • 21. Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.
    Hagenaars N; Verheul RJ; Mooren I; de Jong PH; Mastrobattista E; Glansbeek HL; Heldens JG; van den Bosch H; Hennink WE; Jiskoot W
    J Control Release; 2009 Dec; 140(2):126-33. PubMed ID: 19712713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease.
    Souza CK; Rajão DS; Sandbulte MR; Lopes S; Lewis NS; Loving CL; Gauger PC; Vincent AL
    Vaccine; 2018 Oct; 36(41):6103-6110. PubMed ID: 30181048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel scalable fabrication process for the production of dissolving microneedle arrays.
    Chen H; Wu B; Zhang M; Yang P; Yang B; Qin W; Wang Q; Wen X; Chen M; Quan G; Pan X; Wu C
    Drug Deliv Transl Res; 2019 Feb; 9(1):240-248. PubMed ID: 30341765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination.
    Naito S; Ito Y; Kiyohara T; Kataoka M; Ochiai M; Takada K
    Vaccine; 2012 Feb; 30(6):1191-7. PubMed ID: 22172508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8
    Soema PC; Rosendahl Huber SK; Willems GJ; Jacobi R; Hendriks M; Soethout E; Jiskoot W; de Jonge J; van Beek J; Kersten GFA; Amorij JP
    Front Immunol; 2018; 9():525. PubMed ID: 29593747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
    Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
    Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature.
    Vassilieva EV; Kalluri H; McAllister D; Taherbhai MT; Esser ES; Pewin WP; Pulit-Penaloza JA; Prausnitz MR; Compans RW; Skountzou I
    Drug Deliv Transl Res; 2015 Aug; 5(4):360-71. PubMed ID: 25895053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization.
    Bhide Y; Dong W; Gribonika I; Voshart D; Meijerhof T; de Vries-Idema J; Norley S; Guilfoyle K; Skeldon S; Engelhardt OG; Boon L; Christensen D; Lycke N; Huckriede A
    Front Immunol; 2019; 10():646. PubMed ID: 30984200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring Prime-Boost Vaccination Regimens with Different H1N1 Swine Influenza A Virus Strains and Vaccine Platforms.
    Parys A; Vandoorn E; Chiers K; Passvogel K; Fuchs W; Mettenleiter TC; Van Reeth K
    Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine.
    Patil HP; Murugappan S; ter Veer W; Meijerhof T; de Haan A; Frijlink HW; Wilschut J; Hinrichs WL; Huckriede A
    J Control Release; 2014 Jan; 174():51-62. PubMed ID: 24269505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
    Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
    Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of membrane fusion activity of a whole inactivated influenza virus vaccine in (re)activation of influenza-specific cytotoxic T lymphocytes.
    Budimir N; Meijerhof T; Wilschut J; Huckriede A; de Haan A
    Vaccine; 2010 Dec; 28(52):8280-7. PubMed ID: 20965298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Lipid/DNA Adjuvant-Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus Challenge.
    Carroll TD; Jegaskanda S; Matzinger SR; Fritts L; McChesney MB; Kent SJ; Fairman J; Miller CJ
    J Infect Dis; 2018 Aug; 218(6):856-867. PubMed ID: 29701840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced pulmonary immunization with aerosolized inactivated influenza vaccine containing delta inulin adjuvant.
    Murugappan S; Frijlink HW; Petrovsky N; Hinrichs WL
    Eur J Pharm Sci; 2015 Jan; 66():118-22. PubMed ID: 25459531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine.
    Hagenaars N; Mania M; de Jong P; Que I; Nieuwland R; Slütter B; Glansbeek H; Heldens J; van den Bosch H; Löwik C; Kaijzel E; Mastrobattista E; Jiskoot W
    J Control Release; 2010 May; 144(1):17-24. PubMed ID: 20100528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tip-Loaded Dissolvable Microneedle Arrays Effectively Deliver Polymer-Conjugated Antibody Inhibitors of Tumor-Necrosis-Factor-Alpha Into Human Skin.
    Korkmaz E; Friedrich EE; Ramadan MH; Erdos G; Mathers AR; Ozdoganlar OB; Washburn NR; Falo LD
    J Pharm Sci; 2016 Nov; 105(11):3453-3457. PubMed ID: 27544434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal influenza immunization with vaccine-coated microneedle arrays.
    Koutsonanos DG; del Pilar Martin M; Zarnitsyn VG; Sullivan SP; Compans RW; Prausnitz MR; Skountzou I
    PLoS One; 2009; 4(3):e4773. PubMed ID: 19274084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex bias in mouse humoral immune response to influenza vaccine depends on the vaccine type.
    Živković I; Petrović R; Arsenović-Ranin N; Petrušić V; Minić R; Bufan B; Popović O; Leposavić G
    Biologicals; 2018 Mar; 52():18-24. PubMed ID: 29426673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: A proof of concept study.
    Rodgers AM; McCrudden MTC; Vincente-Perez EM; Dubois AV; Ingram RJ; Larrañeta E; Kissenpfennig A; Donnelly RF
    Int J Pharm; 2018 Oct; 549(1-2):87-95. PubMed ID: 30048778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.